Edmond de Rothschild (Suisse)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$745K Sell
2,381
-359
-13% -$106K 0.23% 99
2016
Q2
$663K Buy
2,740
+2,690
+5,380% +$709K 0.22% 100
2016
Q1
$13K Buy
+50
New +$13.2K 0.01% 332

Other funds holding BIIB

Edmond de Rothschild (Suisse)'s BIIB Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) reduced its Biogen (BIIB) stake by 13% in Q3 2016, selling an estimated $106K and leaving 2,381 shares worth $745K. The position accounts for 0.23% of the portfolio, ranked #99.

Edmond de Rothschild (Suisse) first reported a position in BIIB in Q1 2016 and has held it in 3 quarters since. 1,013 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 2,381 shares of Biogen worth $745K as of Q3 2016.
  • Edmond de Rothschild (Suisse) sold 359 Biogen shares in Q3 2016, an estimated $106K.
  • Biogen made up 0.23% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #99 holding.
  • Edmond de Rothschild (Suisse) first reported a position in Biogen in Q1 2016 and has held it in 3 quarters since.
  • 1,013 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.